Qiandao Fund logo

Qiandao Fund

Asia, Beijing, China, Beijing

Description

Qiandao Fund is a Beijing-based asset manager.

Investor Profile

Qiandao Fund has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Manufacturing, Biotechnology, Health Care.

Stage Focus

  • Series B (67%)
  • Series A (33%)

Country Focus

  • China (67%)
  • United States (33%)

Industry Focus

  • Manufacturing
  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Consumer Goods
  • Product Research
  • Association
  • Non Profit
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Qiandao Fund frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Ligong investment
Asia, Shanghai, China, Putuo
Co-Investments: 2
Sunshine Insurance Group
Asia, Beijing, China, Beijing
Co-Investments: 2
DT Capital Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
BC
North America, California, United States, Palo Alto
Co-Investments: 1
China Merchants Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
Huajin Capital
Asia, Guangdong, China, Zhuhai
Co-Investments: 2
XT
Asia, Zhejiang, China, Ningbo
Co-Investments: 2
Horus Capital
Asia, Shandong, China, Qingdao Shi
Co-Investments: 2

What are some of recent deals done by Qiandao Fund?

Axiata

Suzhou, Jiangsu, China

Axiata is a research, development, and manufacturing company of biomedical consumables.

Health CareManufacturingMedicalMedical Device
Series ASep 19, 2023
Amount Raised: $13,705,013
Norson Biotechnology

Pingdu, Shandong, China

Norson Biotechnology produces edible probiotic powders, fermented lactic acid bacteria beverages, and other products.

BiotechnologyConsumer GoodsProduct Research
Series BJun 8, 2020
Amount Raised: $70,708,356
MabPlex International

Fremont, California, United States

MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals.

AssociationBiotechnologyManufacturingNon Profit
Series BJun 8, 2020
Amount Raised: $70,708,356